Agios Pharmaceuticals, Inc. (AGIO)
35.20
+1.01
(+2.95%)
USD |
NASDAQ |
Apr 02, 16:00
35.20
0.00 (0.00%)
Pre-Market: 08:25
Agios Pharmaceuticals SG&A Expense (TTM) : 180.28M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.09B |
| Biogen, Inc. | 2.434B |
| Catalyst Pharmaceuticals, Inc. | 171.18M |
| Apellis Pharmaceuticals, Inc. | 550.26M |
| Alnylam Pharmaceuticals, Inc. | 1.211B |